Vitamin D resistant hypophosphataemic osteomalacia: treatment with 1alpha-hydroxyvitamin D3
- PMID: 203418
- DOI: 10.1111/j.1365-2265.1977.tb03387.x
Vitamin D resistant hypophosphataemic osteomalacia: treatment with 1alpha-hydroxyvitamin D3
Abstract
Ten patients with vitamin D resistant hypophosphataemic osteomalacia are described. They had hypophosphataemia with a decreased tubular reabsorption of phosphate, malabsorption of calcium and phosphorus, proximal myopathy and extensive osteomalacic changes on iliac crest bone biopsy. The plasma alkaline phosphatase and urine hydroxyproline, however, were raised in only some of the patients. Treatment with 1alpha-hydroxyvitamin D3 in high doses rapidly cured the myopathy, increased calcium and phosphorus absorption and retention and healed the osteomalacia. Phosphorus supplements were not required.
Similar articles
-
Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.J Clin Invest. 1980 Nov;66(5):1020-32. doi: 10.1172/JCI109930. J Clin Invest. 1980. PMID: 6253520 Free PMC article.
-
1alpha-hydroxyvitamin D3 in the treatment of nutritional and metabolic rickets and osteomalacia.Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:239s-244s. doi: 10.1111/j.1365-2265.1977.tb03388.x. Clin Endocrinol (Oxf). 1977. PMID: 203419
-
Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3.Calcif Tissue Res. 1977 May;22 Suppl:55-62. doi: 10.1007/BF02064041. Calcif Tissue Res. 1977. PMID: 912585 No abstract available.
-
The kidney as an endocrine organ involved in the function of vitamin D.Am J Med. 1975 Jan;58(1):39-47. doi: 10.1016/0002-9343(75)90531-8. Am J Med. 1975. PMID: 163578 Review.
-
Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features.Clin Endocrinol (Oxf). 1995 Oct;43(4):479-90. doi: 10.1111/j.1365-2265.1995.tb02621.x. Clin Endocrinol (Oxf). 1995. PMID: 7586624 Review.
Cited by
-
Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia.J Clin Pharmacol. 2016 Feb;56(2):176-85. doi: 10.1002/jcph.570. Epub 2015 Aug 11. J Clin Pharmacol. 2016. PMID: 26073451 Free PMC article. Clinical Trial.
-
Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.J Clin Invest. 1980 Nov;66(5):1020-32. doi: 10.1172/JCI109930. J Clin Invest. 1980. PMID: 6253520 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources